Arya Mariam Roy
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
235
Citations
715
Est. group size
~14
Recurring co-author estimate
Active years
31
Publishing since 1996
Arya Mariam Roy works on breast cancer research using large clinical and population-based datasets, focusing on treatment decisions (such as chemotherapy use guided by genomic tests like Oncotype DX), cancer staging systems, and disparities in cancer outcomes based on socioeconomic and geographic factors. The work also touches on other cancers (prostate, uterine) and broader oncology practice issues like palliative care access and clinical AI tools.
Publication output has grown substantially over the last decade, rising from very few papers before 2019 to a peak of 60 in 2024, with high but slightly declining activity in 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- PS5-06-07: A case report of veno-occlusive disease (VOD) in a patient with metastatic triple-negative breast cancer receiving trastuzumab deruxtecan
Clinical Cancer Research · 2026
- Abstract 6646: Impact of histology subtypes (ductal, lobular, and mixed ductal/lobular) on pathological complete response (pCR) following neoadjuvant chemotherapy (NAC) and chemoimmunotherapy (NACI) for estrogen receptor low (ER-low) HER2-negative breast cancer.
Cancer Research · 2026
- Chemotherapy use among women < 50 years with hormone receptor–positive breast cancer with low (≤15) Oncotype DX 21-gene recurrence score: A National Cancer Database (NCDB) analysis.
Journal of Clinical Oncology · 2026
- Chemotherapy use among women < 50 years with node-negative early-stage hormone receptor–positive breast cancer with intermediate OncotypeDX 21-gene recurrence score: A National Cancer Database analysis.
Journal of Clinical Oncology · 2026
- Sociodemographic and clinical characteristics of women < 50 years and impact on adjuvant chemotherapy decisions across OncotypeDX RS or unknown OncotypeDX categories. A National Cancer Database (NCDB) analysis.
Journal of Clinical Oncology · 2026
- Adjuvant chemotherapy (CT) benefit in invasive lobular carcinoma (ILC) by Oncotype DX Recurrence Score and menopausal status.
Journal of Clinical Oncology · 2026
- Clinical-genomic discordance and chemotherapy (CT) outcomes in early-stage HR+/HER2– invasive lobular carcinoma.
Journal of Clinical Oncology · 2026
- OncoSphere AI: An agentic AI multidisciplinary clinical workflow support tool.
Journal of Clinical Oncology · 2026
- Practice disparities in palliative care utilization across different solid malignancies in the United States: Geographic trends and impact on hospital outcomes.
Journal of Clinical Oncology · 2026
- The American Joint Committee on Cancer (AJCC) Breast Cancer Staging, Eighth Edition, is more Reflective of Cancer Biology than the Seventh Edition
Annals of Surgical Oncology · 2025
- International Medical Graduates Representation at International Oncology Conference Meetings: An Analysis of ASCO Annual Meetings
JCO Oncology Practice · 2025
- Incidence and survival outcomes of breast cancer subtypes in the United States.
Journal of Clinical Oncology · 2025
- Area deprivation index and breast cancer outcomes among patients in Western New York
Breast Cancer Research and Treatment · 2025
- ASO Visual Abstract: The American Joint Committee on Cancer (AJCC) Breast Cancer Staging 8th Edition is More Reflective of Cancer Biology Than the 7th Edition
Annals of Surgical Oncology · 2025
- Cer mortality in patients with systemic lupus erythematosus
Journal of Investigative Medicine · 2025
- Journal of Clinical Oncology×64
- Blood×39
- Cancer Research×20
- Clinical Cancer Research×13
- Research Square×7
- Kai Johnson
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Mathew Cherian
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Julie Stephens
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Emily Burke
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Nicole Williams
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile